CHLORTHALIDONE

CHLORTHALIDONE was reported 11779 times

CHLORTHALIDONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COCKROACH ALLERGY 9 0.1875
1 LICHEN PLANOPILARIS 19 0.1610
2 FIBRILLARY GLOMERULONEPHRITIS 8 0.1379
3 HEMIHYPOAESTHESIA 20 0.0570
4 HEMIPARAESTHESIA 21 0.0538
5 RENIN INCREASED 12 0.0440
6 SPINAL CORD ABSCESS 11 0.0403
7 MILK-ALKALI SYNDROME 19 0.0363
8 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 32 0.0301
9 VENTILATION PERFUSION MISMATCH 8 0.0285
10 ABDOMINAL WALL HAEMORRHAGE 7 0.0268
11 ALLERGY TEST POSITIVE 9 0.0199
12 DIARRHOEA INFECTIOUS 15 0.0190
13 NEPHROGENIC ANAEMIA 88 0.0190
14 POOR PERSONAL HYGIENE 9 0.0174
15 CHOROIDAL EFFUSION 14 0.0174
16 HYPERPARATHYROIDISM SECONDARY 43 0.0171
17 MEAN CELL VOLUME ABNORMAL 8 0.0169
18 ALLERGY TO ANIMAL 17 0.0159
19 MITE ALLERGY 9 0.0137
20 PNEUMONIA VIRAL 43 0.0135
21 RENAL ARTERY STENOSIS 18 0.0131
22 TRYPTASE INCREASED 9 0.0126
23 C-REACTIVE PROTEIN DECREASED 8 0.0123
24 REBOUND ACID HYPERSECRETION 36 0.0119
25 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 13 0.0117
26 BLOOD IMMUNOGLOBULIN M DECREASED 10 0.0100
27 AORTIC DILATATION 11 0.0099
28 DELAYED GRAFT FUNCTION 7 0.0098
29 MENINGITIS ASEPTIC 43 0.0096
30 METABOLIC ALKALOSIS 15 0.0093
31 BLOOD PRESSURE SYSTOLIC ABNORMAL 22 0.0089
32 BREATH SOUNDS ABNORMAL 42 0.0085
33 RECTAL PROLAPSE 10 0.0083
34 BONE DEMINERALISATION 8 0.0076
35 RIGHT VENTRICULAR DYSFUNCTION 8 0.0073
36 DUST ALLERGY 7 0.0071
37 ANGLE CLOSURE GLAUCOMA 18 0.0070
38 BLADDER TRANSITIONAL CELL CARCINOMA 10 0.0070
39 NODAL RHYTHM 10 0.0068
40 CAROTID ARTERIOSCLEROSIS 7 0.0068
41 SYSTEMIC INFECTION 11 0.0066
42 INTERVERTEBRAL DISC OPERATION 8 0.0064
43 MYELITIS TRANSVERSE 9 0.0064
44 END STAGE RENAL DISEASE 116 0.0064
45 CARDIAC MURMUR 55 0.0064
46 INFUSION SITE DISCHARGE 11 0.0063
47 NOCARDIOSIS 16 0.0063
48 PRODUCT MONITORING ERROR 9 0.0062
49 AORTIC ARTERIOSCLEROSIS 16 0.0062
50 CHRONIC KIDNEY DISEASE 461 0.0061
51 AMYLOIDOSIS 10 0.0058
52 RECALLED PRODUCT 10 0.0058
53 CATAPLEXY 8 0.0056
54 ESSENTIAL HYPERTENSION 10 0.0055
55 MEAN CELL VOLUME INCREASED 14 0.0054
56 HYPONATRAEMIA 307 0.0054
57 ACTINIC KERATOSIS 14 0.0054
58 SACROILIITIS 10 0.0053
59 BLOOD POTASSIUM DECREASED 156 0.0052
60 STRESS CARDIOMYOPATHY 30 0.0052
61 BLOOD PRESSURE DIASTOLIC ABNORMAL 13 0.0051
62 INFUSION SITE BRUISING 11 0.0051
63 KYPHOSIS 9 0.0051
64 HYPOKALAEMIA 235 0.0051
65 BLOOD MAGNESIUM DECREASED 42 0.0049
66 RENAL MASS 10 0.0048
67 HYPERPARATHYROIDISM 10 0.0048
68 LEFT VENTRICULAR HYPERTROPHY 20 0.0047
69 BLOOD PRESSURE INADEQUATELY CONTROLLED 28 0.0046
70 CHRONIC SINUSITIS 17 0.0045
71 BLOOD POTASSIUM ABNORMAL 12 0.0045
72 GASTROINTESTINAL HYPOMOTILITY 10 0.0044
73 SPINAL STENOSIS 18 0.0044
74 SUSPECTED SUICIDE 20 0.0043
75 DIASTOLIC DYSFUNCTION 13 0.0042
76 RADICULOPATHY 11 0.0042
77 HYPERKERATOSIS 23 0.0042
78 PROSTATOMEGALY 16 0.0041
79 GLOMERULAR FILTRATION RATE DECREASED 50 0.0041
80 RENAL HAEMORRHAGE 8 0.0039
81 AKINESIA 8 0.0039
82 PROTEIN URINE PRESENT 19 0.0038
83 URINARY BLADDER HAEMORRHAGE 8 0.0038
84 BLOOD IMMUNOGLOBULIN E INCREASED 9 0.0037
85 IRON DEFICIENCY ANAEMIA 34 0.0037
86 INFUSION SITE HAEMORRHAGE 12 0.0036
87 ANORECTAL DISORDER 7 0.0035
88 INFUSION SITE PRURITUS 11 0.0035
89 RENAL INJURY 103 0.0035
90 PARAPLEGIA 10 0.0035
91 HEPATITIS TOXIC 9 0.0035
92 RHINITIS ALLERGIC 15 0.0034
93 SINUS OPERATION 8 0.0034
94 HYPERLACTACIDAEMIA 9 0.0034
95 TUBULOINTERSTITIAL NEPHRITIS 61 0.0033
96 SEASONAL ALLERGY 46 0.0032
97 TACHYARRHYTHMIA 8 0.0032
98 BLOOD POTASSIUM INCREASED 52 0.0032
99 DIVERTICULUM INTESTINAL 14 0.0032
100 INFUSION SITE SWELLING 20 0.0032
101 HEPATOSPLENOMEGALY 8 0.0031
102 ACUTE KIDNEY INJURY 476 0.0031
103 SINUS BRADYCARDIA 30 0.0031
104 BLOOD CHLORIDE DECREASED 8 0.0031
105 BENIGN PROSTATIC HYPERPLASIA 16 0.0031
106 PRODUCT ADMINISTRATION INTERRUPTED 24 0.0031
107 PRESYNCOPE 73 0.0030
108 NEPHROPATHY 28 0.0030
109 ARTERIOSCLEROSIS 28 0.0030
110 SPINAL OSTEOARTHRITIS 26 0.0030
111 GOUT 53 0.0030
112 DYSLIPIDAEMIA 15 0.0030
113 SCOLIOSIS 18 0.0029
114 IRON DEFICIENCY 13 0.0029
115 RED CELL DISTRIBUTION WIDTH INCREASED 12 0.0029
116 POLYMYALGIA RHEUMATICA 9 0.0028
117 HYPERVOLAEMIA 14 0.0028
118 SQUAMOUS CELL CARCINOMA OF SKIN 17 0.0028
119 IMPAIRED GASTRIC EMPTYING 38 0.0028
120 RENAL CYST 22 0.0028
121 BLOOD PRESSURE SYSTOLIC INCREASED 54 0.0028
122 LYMPHOEDEMA 19 0.0027
123 PRE-EXISTING CONDITION IMPROVED 17 0.0027
124 PLANTAR FASCIITIS 9 0.0027
125 HYPERKALAEMIA 94 0.0027
126 HEPATIC STEATOSIS 49 0.0026
127 BLOOD PRESSURE INCREASED 400 0.0026
128 MENISCUS INJURY 16 0.0026
129 ARTHRITIS INFECTIVE 12 0.0026
130 AORTIC STENOSIS 9 0.0026
131 BLOOD PRESSURE FLUCTUATION 62 0.0026
132 INTERVERTEBRAL DISC DISORDER 11 0.0026
133 SLEEP APNOEA SYNDROME 49 0.0026
134 RENAL TUBULAR NECROSIS 25 0.0025
135 BLOOD SODIUM DECREASED 48 0.0025
136 POLYDIPSIA 10 0.0025
137 HYPOVOLAEMIC SHOCK 12 0.0025
138 VENTRICULAR HYPOKINESIA 8 0.0025
139 ATELECTASIS 24 0.0025
140 EOSINOPHILIA 43 0.0025
141 DUODENAL ULCER HAEMORRHAGE 7 0.0024
142 SINUS CONGESTION 33 0.0024
143 HYPERTENSIVE CRISIS 27 0.0024
144 RENAL IMPAIRMENT 203 0.0024
145 ABDOMINAL HERNIA 11 0.0024
146 RENAL FAILURE 319 0.0024
147 HYPOCALCAEMIA 45 0.0024
148 BLOOD PRESSURE ABNORMAL 47 0.0024
149 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 24 0.0023
150 BLOOD UREA INCREASED 39 0.0023
151 BASAL CELL CARCINOMA 36 0.0023
152 GRIP STRENGTH DECREASED 20 0.0023
153 BONE EROSION 8 0.0023
154 RALES 13 0.0022
155 HYPOMAGNESAEMIA 31 0.0022
156 BRONCHIECTASIS 15 0.0022
157 HYPOVOLAEMIA 13 0.0022
158 RHABDOMYOLYSIS 92 0.0022
159 GOITRE 9 0.0022
160 VITAMIN D DECREASED 18 0.0021
161 UPPER RESPIRATORY TRACT INFECTION 97 0.0021
162 POLYURIA 17 0.0021
163 ATRIOVENTRICULAR BLOCK 16 0.0021
164 BLOOD CREATININE INCREASED 135 0.0021
165 ORTHOSTATIC HYPOTENSION 36 0.0021
166 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
167 BODY HEIGHT DECREASED 22 0.0021
168 RHINOVIRUS INFECTION 8 0.0021
169 PRODUCTIVE COUGH 98 0.0021
170 NEPHROTIC SYNDROME 14 0.0020
171 MULTIPLE ALLERGIES 16 0.0020
172 NAIL DISCOLOURATION 8 0.0020
173 BLOOD PRESSURE DIASTOLIC DECREASED 15 0.0020
174 BLOOD CREATININE ABNORMAL 7 0.0020
175 DIABETIC NEUROPATHY 10 0.0020
176 INFUSION SITE ERYTHEMA 17 0.0020
177 PULMONARY MASS 30 0.0020
178 CAROTID ARTERY STENOSIS 7 0.0020
179 SPUTUM DISCOLOURED 19 0.0020
180 TYPE 1 DIABETES MELLITUS 12 0.0020
181 RESTLESS LEGS SYNDROME 36 0.0020
182 URINE ABNORMALITY 9 0.0020
183 PERIPHERAL SWELLING 304 0.0020
184 SPINAL FUSION SURGERY 8 0.0020
185 DIZZINESS POSTURAL 19 0.0020
186 TRIGGER FINGER 8 0.0020
187 INCREASED TENDENCY TO BRUISE 18 0.0020
188 CARDIAC FAILURE ACUTE 13 0.0019
189 FOOT FRACTURE 37 0.0019
190 EYE INFECTION 22 0.0019
191 IMPAIRED QUALITY OF LIFE 28 0.0019
192 HYPERCALCAEMIA 24 0.0019
193 BLOOD CALCIUM INCREASED 17 0.0019
194 HYPERTENSION 410 0.0019
195 SKIN TIGHTNESS 9 0.0019
196 ORAL DISORDER 14 0.0019
197 LOCALISED INFECTION 46 0.0019
198 NOCTURIA 23 0.0019
199 PROSTATIC SPECIFIC ANTIGEN INCREASED 26 0.0019
200 HEART RATE DECREASED 66 0.0019
201 OEDEMA PERIPHERAL 229 0.0019
202 HAEMOGLOBIN ABNORMAL 12 0.0019
203 SLUGGISHNESS 19 0.0019
204 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
205 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 97 0.0019
206 PRODUCT RESIDUE PRESENT 10 0.0019
207 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
208 POST PROCEDURAL INFECTION 15 0.0018
209 OSTEOARTHRITIS 78 0.0018
210 SKIN LACERATION 20 0.0018
211 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16 0.0018
212 BODY TEMPERATURE DECREASED 18 0.0018
213 ANHEDONIA 48 0.0018
214 OBESITY 29 0.0018
215 HAEMORRHAGIC ANAEMIA 8 0.0018
216 FOOD ALLERGY 14 0.0018
217 WHEEZING 107 0.0018
218 SPINAL PAIN 21 0.0018
219 GASTROOESOPHAGEAL REFLUX DISEASE 144 0.0018
220 HAEMOLYTIC ANAEMIA 16 0.0018
221 INFUSION SITE PAIN 23 0.0018
222 GLYCOSYLATED HAEMOGLOBIN INCREASED 45 0.0018
223 NASAL CONGESTION 104 0.0018
224 DEHYDRATION 235 0.0018
225 DECREASED ACTIVITY 19 0.0018
226 LOWER RESPIRATORY TRACT INFECTION 80 0.0018
227 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
228 JOINT STIFFNESS 46 0.0018
229 EXOSTOSIS 16 0.0018
230 PERIPHERAL VASCULAR DISORDER 9 0.0017
231 HOT FLUSH 131 0.0017
232 SKIN ATROPHY 10 0.0017
233 BLOOD CHOLESTEROL ABNORMAL 8 0.0017
234 BLOOD URIC ACID INCREASED 10 0.0017
235 BACK DISORDER 28 0.0017
236 HYPOPHAGIA 44 0.0017
237 URINE OUTPUT DECREASED 15 0.0017
238 ECONOMIC PROBLEM 26 0.0017
239 CARPAL TUNNEL SYNDROME 24 0.0017
240 POLYARTHRITIS 9 0.0017
241 NEPHROLITHIASIS 78 0.0017
242 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
243 EMPHYSEMA 17 0.0017
244 CATARACT OPERATION 10 0.0017
245 PROTEINURIA 32 0.0017
246 WALKING AID USER 11 0.0017
247 SEROTONIN SYNDROME 32 0.0017
248 HYPOTHYROIDISM 53 0.0017
249 LUPUS-LIKE SYNDROME 15 0.0017
250 ARTERIAL OCCLUSIVE DISEASE 13 0.0017
251 POOR VENOUS ACCESS 17 0.0016
252 CARDIAC FAILURE CHRONIC 7 0.0016
253 HORMONE LEVEL ABNORMAL 8 0.0016
254 ELECTROLYTE IMBALANCE 19 0.0016
255 NERVE COMPRESSION 15 0.0016
256 SPINAL OPERATION 20 0.0016
257 COAGULOPATHY 27 0.0016
258 HEPATIC ENCEPHALOPATHY 15 0.0016
259 INFUSION SITE EXTRAVASATION 10 0.0016
260 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 77 0.0016
261 HYDRONEPHROSIS 12 0.0016
262 BREAST PAIN 17 0.0016
263 MITRAL VALVE INCOMPETENCE 18 0.0016
264 OSTEOPENIA 24 0.0016
265 BLOOD CREATINE INCREASED 7 0.0016
266 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
267 CATHETERISATION CARDIAC 7 0.0016
268 SYNCOPE 156 0.0016
269 POLLAKIURIA 65 0.0016
270 WOUND INFECTION 17 0.0016
271 ATRIAL FIBRILLATION 151 0.0015
272 METABOLIC DISORDER 9 0.0015
273 MUSCLE TIGHTNESS 25 0.0015
274 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
275 VITAMIN D DEFICIENCY 15 0.0015
276 SPLENOMEGALY 18 0.0015
277 CORONARY ARTERY OCCLUSION 21 0.0015
278 BRAIN FOG 24 0.0015
279 DRUG LEVEL ABOVE THERAPEUTIC 7 0.0015
280 HAIR COLOUR CHANGES 19 0.0015
281 SOMNAMBULISM 10 0.0015
282 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
283 SINUS DISORDER 30 0.0015
284 CARDIAC PACEMAKER INSERTION 9 0.0015
285 APPETITE DISORDER 10 0.0015
286 MACULAR DEGENERATION 18 0.0015
287 RIB FRACTURE 31 0.0015
288 SCIATICA 24 0.0015
289 ATRIAL FLUTTER 12 0.0015
290 MALIGNANT MELANOMA 20 0.0015
291 HEREDITARY ANGIOEDEMA 16 0.0015
292 BLOOD PRESSURE DECREASED 99 0.0015
293 PLATELET COUNT ABNORMAL 9 0.0015
294 MYASTHENIA GRAVIS 12 0.0015
295 INGUINAL HERNIA 9 0.0015
296 SPINAL DISORDER 14 0.0015
297 PRODUCT TASTE ABNORMAL 20 0.0015
298 DRUG ERUPTION 26 0.0015
299 SPINAL COMPRESSION FRACTURE 12 0.0014
300 JOINT INJURY 31 0.0014
301 AORTIC ANEURYSM 11 0.0014
302 BRONCHITIS 107 0.0014
303 COVID-19 PNEUMONIA 17 0.0014
304 BRADYCARDIA 76 0.0014
305 BLOOD IRON DECREASED 17 0.0014
306 CONCUSSION 11 0.0014
307 NEUROPATHY PERIPHERAL 135 0.0014
308 DRUG INTERACTION 225 0.0014
309 CHROMATURIA 32 0.0014
310 EJECTION FRACTION DECREASED 22 0.0014
311 PERIORBITAL SWELLING 8 0.0014
312 NECK PAIN 79 0.0014
313 ABDOMINAL TENDERNESS 7 0.0014
314 PERONEAL NERVE PALSY 8 0.0014
315 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
316 ROTATOR CUFF SYNDROME 18 0.0014
317 VENTRICULAR TACHYCARDIA 23 0.0014
318 MUSCULOSKELETAL STIFFNESS 122 0.0014
319 TOOTHACHE 25 0.0014
320 CORONARY ARTERIAL STENT INSERTION 7 0.0014
321 BRADYPHRENIA 9 0.0014
322 FAECES SOFT 10 0.0014
323 TOOTH INFECTION 18 0.0014
324 CANDIDA INFECTION 23 0.0014
325 OSTEOPOROSIS 56 0.0014
326 WOUND 38 0.0014
327 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
328 ANKLE FRACTURE 21 0.0014
329 TENDONITIS 21 0.0014
330 MUSCULAR WEAKNESS 154 0.0014
331 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 23 0.0014
332 DYSPNOEA EXERTIONAL 51 0.0014
333 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
334 ABNORMAL FAECES 11 0.0013
335 JOINT RANGE OF MOTION DECREASED 18 0.0013
336 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
337 HAIR DISORDER 11 0.0013
338 PHARYNGEAL SWELLING 13 0.0013
339 HEAD INJURY 42 0.0013
340 ARTHRITIS 104 0.0013
341 CONSTIPATION 288 0.0013
342 TREATMENT NONCOMPLIANCE 72 0.0013
343 EAR INFECTION 35 0.0013
344 LIGAMENT SPRAIN 13 0.0013
345 ANGIOEDEMA 58 0.0013
346 NODULE 17 0.0013
347 BLOOD TRIGLYCERIDES INCREASED 23 0.0013
348 POOR QUALITY SLEEP 28 0.0013
349 EYE PAIN 73 0.0013
350 FEELING COLD 36 0.0013
351 OLIGURIA 8 0.0013
352 HEART RATE IRREGULAR 29 0.0013
353 DISEASE RECURRENCE 61 0.0013
354 SUBARACHNOID HAEMORRHAGE 13 0.0013
355 TORSADE DE POINTES 10 0.0013
356 ASTHMA 144 0.0013
357 KIDNEY INFECTION 25 0.0013
358 MUSCLE STRAIN 11 0.0013
359 COVID-19 223 0.0013
360 TOOTH FRACTURE 14 0.0013
361 FLATULENCE 72 0.0013
362 BLOOD CHOLESTEROL INCREASED 59 0.0013
363 MUSCLE ATROPHY 16 0.0013
364 PULMONARY EMBOLISM 120 0.0013
365 HYPOTENSION 253 0.0013
366 URINARY TRACT INFECTION 215 0.0013
367 TRICUSPID VALVE INCOMPETENCE 10 0.0013
368 ULCER 20 0.0013
369 SWELLING 117 0.0012
370 ACUTE PULMONARY OEDEMA 7 0.0012
371 JOINT SWELLING 150 0.0012
372 FACIAL PAIN 11 0.0012
373 DERMATITIS CONTACT 14 0.0012
374 DIABETES MELLITUS 93 0.0012
375 BACK PAIN 283 0.0012
376 CEREBRAL DISORDER 9 0.0012
377 WEIGHT DECREASED 339 0.0012
378 DYSGRAPHIA 8 0.0012
379 NIGHT SWEATS 39 0.0012
380 HAEMATOCRIT DECREASED 24 0.0012
381 COUGH 338 0.0012
382 DIZZINESS 600 0.0012
383 PANCREATITIS ACUTE 27 0.0012
384 SKIN ULCER 31 0.0012
385 INTENTIONAL PRODUCT USE ISSUE 105 0.0012
386 PAROSMIA 9 0.0012
387 NEURALGIA 29 0.0012
388 DIVERTICULITIS 33 0.0012
389 CELLULITIS 60 0.0012
390 SINUSITIS 122 0.0012
391 RESPIRATORY TRACT INFECTION 31 0.0012
392 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
393 ASTHENIA 447 0.0012
394 ERUCTATION 23 0.0012
395 METABOLIC ACIDOSIS 38 0.0012
396 DECREASED INTEREST 7 0.0012
397 BLOOD GLUCOSE FLUCTUATION 13 0.0012
398 HYPERSOMNIA 34 0.0012
399 PRODUCT DISTRIBUTION ISSUE 11 0.0012
400 SEDATION 31 0.0012
401 HAEMODYNAMIC INSTABILITY 9 0.0012
402 FATIGUE 919 0.0012
403 HYPERGLYCAEMIA 43 0.0012
404 HAEMORRHOIDS 23 0.0012
405 LIMB INJURY 32 0.0012
406 CONTUSION 113 0.0012
407 FACIAL PARALYSIS 10 0.0012
408 FOOT DEFORMITY 13 0.0012
409 GINGIVAL BLEEDING 16 0.0012
410 PHOTOPHOBIA 22 0.0012
411 BALANCE DISORDER 101 0.0012
412 AMNESIA 76 0.0012
413 SWELLING FACE 76 0.0012
414 LIVER FUNCTION TEST INCREASED 25 0.0012
415 DYSSTASIA 34 0.0012
416 CARDIAC OPERATION 10 0.0012
417 GASTROENTERITIS VIRAL 21 0.0012
418 TEMPERATURE INTOLERANCE 12 0.0012
419 RENAL DISORDER 54 0.0012
420 CHOLELITHIASIS 38 0.0012
421 CATARACT 69 0.0012
422 PSYCHOLOGICAL TRAUMA 10 0.0012
423 DRY MOUTH 94 0.0012
424 OCULAR DISCOMFORT 13 0.0012
425 BLOOD CALCIUM DECREASED 13 0.0012
426 UPPER LIMB FRACTURE 23 0.0012
427 RED BLOOD CELL COUNT DECREASED 33 0.0012
428 GAIT DISTURBANCE 220 0.0011
429 THERAPY CESSATION 59 0.0011
430 GASTROINTESTINAL INFLAMMATION 9 0.0011
431 HUNGER 16 0.0011
432 PRODUCT ODOUR ABNORMAL 12 0.0011
433 POST PROCEDURAL COMPLICATION 22 0.0011
434 GLAUCOMA 22 0.0011
435 FALL 380 0.0011
436 CARDIOMEGALY 14 0.0011
437 STOMATITIS 69 0.0011
438 GASTROINTESTINAL HAEMORRHAGE 95 0.0011
439 GENERALISED OEDEMA 14 0.0011
440 SKIN LESION 31 0.0011
441 HAND FRACTURE 8 0.0011
442 CYST 14 0.0011
443 CORONARY ARTERY DISEASE 34 0.0011
444 INTENTIONAL DOSE OMISSION 32 0.0011
445 MADAROSIS 13 0.0011
446 QUALITY OF LIFE DECREASED 15 0.0011
447 ANAL INCONTINENCE 10 0.0011
448 FIBROMYALGIA 27 0.0011
449 OROPHARYNGEAL DISCOMFORT 10 0.0011
450 OEDEMA 60 0.0011
451 HAEMATOCHEZIA 61 0.0011
452 MUSCULOSKELETAL DISCOMFORT 19 0.0011
453 GASTRITIS 29 0.0011
454 ARTHRALGIA 458 0.0011
455 MOBILITY DECREASED 79 0.0011
456 HICCUPS 9 0.0011
457 IMPAIRED HEALING 36 0.0011
458 GASTROENTERITIS 16 0.0011
459 UTERINE LEIOMYOMA 8 0.0011
460 DYSPHONIA 64 0.0011
461 BONE PAIN 64 0.0011
462 KNEE ARTHROPLASTY 23 0.0011
463 ERECTILE DYSFUNCTION 28 0.0011
464 MUSCULOSKELETAL PAIN 57 0.0011
465 HYPERLIPIDAEMIA 13 0.0011
466 DIARRHOEA 701 0.0011
467 TASTE DISORDER 22 0.0011
468 RENAL FAILURE ACUTE 46 0.0011
469 UROSEPSIS 10 0.0011
470 TOOTH ABSCESS 11 0.0011
471 EATING DISORDER 23 0.0011
472 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
473 HYPOXIA 38 0.0011
474 RESPIRATORY TRACT CONGESTION 17 0.0011
475 SKIN INFECTION 12 0.0011
476 NIGHTMARE 37 0.0011
477 CYSTITIS 34 0.0011
478 SKIN PLAQUE 9 0.0011
479 RASH ERYTHEMATOUS 51 0.0011
480 GALLBLADDER DISORDER 19 0.0011
481 ORAL CANDIDIASIS 14 0.0011
482 SARS-COV-2 TEST POSITIVE 14 0.0011
483 CORONAVIRUS INFECTION 7 0.0011
484 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
485 TROPONIN INCREASED 8 0.0011
486 WEIGHT FLUCTUATION 11 0.0011
487 DYSPEPSIA 103 0.0010
488 HAIR TEXTURE ABNORMAL 14 0.0010
489 INSURANCE ISSUE 16 0.0010
490 AGEUSIA 26 0.0010
491 MYOPATHY 9 0.0010
492 DECREASED APPETITE 242 0.0010
493 DRY EYE 52 0.0010
494 INCONTINENCE 11 0.0010
495 COLITIS ISCHAEMIC 7 0.0010
496 DYSURIA 38 0.0010
497 HAEMOGLOBIN DECREASED 106 0.0010
498 MYALGIA 175 0.0010
499 ORAL PAIN 23 0.0010
500 ABNORMAL LOSS OF WEIGHT 7 0.0010
501 CHOKING 20 0.0010
502 GROIN PAIN 9 0.0010
503 SKIN DISCOLOURATION 47 0.0010
504 FLUID RETENTION 52 0.0010
505 THERAPY INTERRUPTED 73 0.0010
506 LUNG INFILTRATION 9 0.0010
507 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
508 CARDIOMYOPATHY 15 0.0010
509 NASOPHARYNGITIS 187 0.0010
510 WEIGHT INCREASED 227 0.0010
511 HOSPICE CARE 10 0.0010
512 SKIN HAEMORRHAGE 15 0.0010
513 CARDIAC FAILURE 81 0.0010
514 PRODUCT PRESCRIBING ERROR 24 0.0010
515 THIRST 18 0.0010
516 OROPHARYNGEAL PAIN 93 0.0010
517 HIATUS HERNIA 13 0.0010
518 APHONIA 14 0.0010
519 TINNITUS 46 0.0010
520 BLOOD URINE PRESENT 19 0.0010
521 PLATELET COUNT INCREASED 13 0.0010
522 RASH PRURITIC 54 0.0010
523 DYSGEUSIA 74 0.0010
524 SCAR 17 0.0010
525 ANAEMIA 189 0.0010
526 WHITE BLOOD CELL COUNT INCREASED 38 0.0010
527 NERVE INJURY 11 0.0010
528 BURSITIS 12 0.0010
529 LOWER LIMB FRACTURE 19 0.0010
530 DIVERTICULUM 7 0.0010
531 DYSARTHRIA 37 0.0010
532 BRONCHOSPASM 14 0.0010
533 HIP ARTHROPLASTY 15 0.0010
534 ABDOMINAL PAIN UPPER 201 0.0010
535 MUSCLE SPASMS 179 0.0010
536 SKIN CANCER 21 0.0010
537 INITIAL INSOMNIA 10 0.0010
538 ESCHERICHIA INFECTION 8 0.0010
539 PARAESTHESIA ORAL 14 0.0010
540 PRURITUS 371 0.0010
541 THERAPEUTIC RESPONSE SHORTENED 32 0.0010
542 TOOTH EXTRACTION 12 0.0010
543 MIDDLE INSOMNIA 18 0.0010
544 HEMIPLEGIA 8 0.0010
545 THROAT TIGHTNESS 26 0.0010
546 PULMONARY OEDEMA 43 0.0010
547 LACRIMATION INCREASED 29 0.0010
548 INFLUENZA 107 0.0010
549 LUNG DISORDER 47 0.0010
550 HEPATIC CIRRHOSIS 18 0.0010
551 NAUSEA 758 0.0010
552 DIABETIC KETOACIDOSIS 23 0.0010
553 PAIN IN EXTREMITY 282 0.0010
554 CHEST PAIN 177 0.0010
555 INTESTINAL OBSTRUCTION 36 0.0010
556 FLUSHING 97 0.0010
557 PRODUCT USE COMPLAINT 15 0.0010
558 PERICARDIAL EFFUSION 22 0.0010
559 INFLAMMATION 49 0.0009
560 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
561 DYSPNOEA 537 0.0009
562 SPINAL FRACTURE 19 0.0009
563 GASTRIC ULCER 18 0.0009
564 RENAL PAIN 10 0.0009
565 HYPOAESTHESIA 141 0.0009
566 EYE IRRITATION 54 0.0009
567 RETCHING 20 0.0009
568 FEEDING DISORDER 19 0.0009
569 SNEEZING 21 0.0009
570 HYPERCHOLESTEROLAEMIA 9 0.0009
571 HYPERHIDROSIS 120 0.0009
572 RECTAL HAEMORRHAGE 40 0.0009
573 PARAESTHESIA 146 0.0009
574 PAIN 570 0.0009
575 ABDOMINAL DISCOMFORT 155 0.0009
576 EYE PRURITUS 31 0.0009
577 FAECES DISCOLOURED 20 0.0009
578 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
579 SURGERY 54 0.0009
580 TYPE 2 DIABETES MELLITUS 31 0.0009
581 BLOOD GLUCOSE ABNORMAL 17 0.0009
582 WRIST FRACTURE 11 0.0009
583 ARTHROPATHY 51 0.0009
584 PNEUMONIA 297 0.0009
585 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
586 HAND DEFORMITY 12 0.0009
587 PRODUCT DOSE OMISSION ISSUE 269 0.0009
588 NAIL DISORDER 8 0.0009
589 EYE SWELLING 34 0.0009
590 ILLNESS 94 0.0009
591 THINKING ABNORMAL 17 0.0009
592 DRUG INTOLERANCE 88 0.0009
593 CHEST DISCOMFORT 93 0.0009
594 OXYGEN SATURATION DECREASED 51 0.0009
595 C-REACTIVE PROTEIN INCREASED 33 0.0009
596 INSOMNIA 241 0.0009
597 PRODUCT DOSE OMISSION 59 0.0009
598 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
599 VERTIGO 55 0.0009
600 BLOOD GLUCOSE INCREASED 170 0.0009
601 MENTAL STATUS CHANGES 25 0.0009
602 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
603 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
604 GAIT INABILITY 30 0.0009
605 SPEECH DISORDER 47 0.0009
606 CARDIAC FAILURE CONGESTIVE 72 0.0009
607 THROMBOSIS 72 0.0009
608 FULL BLOOD COUNT DECREASED 18 0.0009
609 FEELING ABNORMAL 214 0.0009
610 GASTROINTESTINAL INFECTION 8 0.0009
611 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
612 HEADACHE 557 0.0009
613 PLEURAL EFFUSION 54 0.0009
614 PRODUCT SUBSTITUTION ISSUE 51 0.0009
615 EYELID PTOSIS 9 0.0009
616 DRY THROAT 9 0.0009
617 ROAD TRAFFIC ACCIDENT 37 0.0009
618 EPISTAXIS 66 0.0009
619 URINARY INCONTINENCE 26 0.0009
620 SKIN EXFOLIATION 74 0.0009
621 HAEMATURIA 30 0.0009
622 INTERNAL HAEMORRHAGE 10 0.0009
623 BLOOD GLUCOSE DECREASED 42 0.0009
624 LIMB DISCOMFORT 27 0.0009
625 ANGINA PECTORIS 25 0.0009
626 IMMUNODEFICIENCY 13 0.0009
627 SKIN FISSURES 17 0.0009
628 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
629 THROAT IRRITATION 39 0.0009
630 ABNORMAL DREAMS 24 0.0009
631 MEMORY IMPAIRMENT 119 0.0009
632 TENDERNESS 9 0.0009
633 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
634 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
635 TRANSFUSION 9 0.0009
636 CONDITION AGGRAVATED 261 0.0009
637 BLOOD COUNT ABNORMAL 13 0.0009
638 CEREBROVASCULAR ACCIDENT 145 0.0009
639 TREMOR 142 0.0009
640 BLISTER 48 0.0009
641 SOMNOLENCE 172 0.0009
642 SCRATCH 9 0.0009
643 SLEEP DISORDER 60 0.0008
644 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
645 VOMITING 398 0.0008
646 ARRHYTHMIA 40 0.0008
647 BURNING SENSATION 59 0.0008
648 MUSCULOSKELETAL DISORDER 16 0.0008
649 EYE INFLAMMATION 8 0.0008
650 POLYNEUROPATHY 10 0.0008
651 DEPRESSION 190 0.0008
652 MALAISE 363 0.0008
653 BACK INJURY 9 0.0008
654 HERNIA 16 0.0008
655 EYE HAEMORRHAGE 11 0.0008
656 EAR PAIN 16 0.0008
657 THROMBOTIC MICROANGIOPATHY 8 0.0008
658 KNEE OPERATION 8 0.0008
659 SMALL INTESTINAL OBSTRUCTION 10 0.0008
660 HAEMATOMA 21 0.0008
661 FUNGAL INFECTION 27 0.0008
662 RASH 353 0.0008
663 MOVEMENT DISORDER 26 0.0008
664 VISION BLURRED 111 0.0008
665 HEART RATE INCREASED 80 0.0008
666 COLON CANCER 12 0.0008
667 MALNUTRITION 9 0.0008
668 GLOSSODYNIA 18 0.0008
669 GASTROINTESTINAL DISORDER 72 0.0008
670 PERIPHERAL COLDNESS 11 0.0008
671 SWOLLEN TONGUE 25 0.0008
672 INJECTION SITE DISCOLOURATION 10 0.0008
673 CONFUSIONAL STATE 129 0.0008
674 RESPIRATORY FAILURE 58 0.0008
675 DEPRESSED MOOD 42 0.0008
676 URTICARIA 133 0.0008
677 COLITIS 30 0.0008
678 VISUAL IMPAIRMENT 98 0.0008
679 HEAD DISCOMFORT 14 0.0008
680 SEPSIS 88 0.0008
681 MICTURITION URGENCY 9 0.0008
682 DEMENTIA 22 0.0008
683 MASS 11 0.0008
684 PRURITUS GENERALISED 17 0.0008
685 ABDOMINAL DISTENSION 82 0.0008
686 NERVOUSNESS 41 0.0008
687 HALLUCINATION 59 0.0008
688 INTRAOCULAR PRESSURE INCREASED 10 0.0008
689 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 141 0.0008
690 PRODUCT DISPENSING ERROR 17 0.0008
691 ACUTE RESPIRATORY FAILURE 15 0.0008
692 EAR DISCOMFORT 8 0.0008
693 URINARY RETENTION 26 0.0008
694 INFLUENZA LIKE ILLNESS 64 0.0008
695 ANAPHYLACTIC SHOCK 20 0.0008
696 MUSCULOSKELETAL CHEST PAIN 12 0.0008
697 VASCULITIS 9 0.0008
698 INFUSION RELATED REACTION 51 0.0008
699 ANXIETY 218 0.0008
700 LETHARGY 44 0.0008
701 STEVENS-JOHNSON SYNDROME 17 0.0008
702 HYPOGLYCAEMIA 37 0.0008
703 INJECTION SITE DISCOMFORT 8 0.0008
704 EYE DISORDER 25 0.0008
705 HYPERTHYROIDISM 11 0.0008
706 THERAPEUTIC PRODUCT EFFECT DECREASED 34 0.0008
707 IMMUNE SYSTEM DISORDER 10 0.0008
708 ANKYLOSING SPONDYLITIS 10 0.0008
709 HYPOKINESIA 11 0.0008
710 FULL BLOOD COUNT ABNORMAL 8 0.0008
711 CHOLECYSTITIS 9 0.0008
712 HYPERSENSITIVITY 140 0.0008
713 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
714 DIARRHOEA HAEMORRHAGIC 7 0.0007
715 PYREXIA 259 0.0007
716 CARDIAC DISORDER 70 0.0007
717 THYROID CANCER 9 0.0007
718 ACUTE MYOCARDIAL INFARCTION 22 0.0007
719 BREAST CANCER METASTATIC 8 0.0007
720 PRODUCT PHYSICAL ISSUE 15 0.0007
721 PALPITATIONS 87 0.0007
722 PAIN OF SKIN 20 0.0007
723 ADRENAL INSUFFICIENCY 9 0.0007
724 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
725 PAIN IN JAW 21 0.0007
726 COLD SWEAT 13 0.0007
727 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
728 PULMONARY THROMBOSIS 8 0.0007
729 RASH GENERALISED 19 0.0007
730 OESOPHAGITIS 8 0.0007
731 COMPLETED SUICIDE 61 0.0007
732 MULTIPLE FRACTURES 12 0.0007
733 ALOPECIA 143 0.0007
734 ABDOMINAL PAIN 169 0.0007
735 LOSS OF CONSCIOUSNESS 93 0.0007
736 PHARYNGITIS 9 0.0007
737 VISUAL ACUITY REDUCED 24 0.0007
738 LEUKOCYTOSIS 13 0.0007
739 OSTEOMYELITIS 13 0.0007
740 CHILLS 84 0.0007
741 RASH MACULAR 25 0.0007
742 CARDIAC ARREST 59 0.0007
743 BLOOD TEST ABNORMAL 10 0.0007
744 PRODUCT USE IN UNAPPROVED INDICATION 176 0.0007
745 HEPATIC CANCER 17 0.0007
746 SINUS TACHYCARDIA 10 0.0007
747 IMPAIRED DRIVING ABILITY 8 0.0007
748 DRUG RESISTANCE 18 0.0007
749 PANCREATITIS 37 0.0007
750 IRRITABLE BOWEL SYNDROME 15 0.0007
751 CEREBRAL HAEMORRHAGE 25 0.0007
752 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
753 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
754 HEPATIC ENZYME INCREASED 47 0.0007
755 FLUID OVERLOAD 10 0.0007
756 INJECTION SITE PRURITUS 46 0.0007
757 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
758 FEELING JITTERY 13 0.0007
759 HAEMOPTYSIS 19 0.0007
760 GYNAECOMASTIA 21 0.0007
761 HYPOACUSIS 29 0.0007
762 PULMONARY HYPERTENSION 14 0.0007
763 MYOCLONUS 8 0.0007
764 MIGRAINE 64 0.0007
765 FEAR 18 0.0007
766 RHINORRHOEA 43 0.0007
767 COGNITIVE DISORDER 31 0.0007
768 DRUG ADMINISTERED AT INAPPROPRIATE SITE 7 0.0007
769 HYPOAESTHESIA ORAL 10 0.0007
770 APHASIA 20 0.0007
771 EXPIRED PRODUCT ADMINISTERED 22 0.0007
772 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
773 INFECTION 95 0.0007
774 DISORIENTATION 26 0.0007
775 EXPOSURE VIA SKIN CONTACT 17 0.0007
776 DIPLOPIA 17 0.0007
777 MUSCLE TWITCHING 15 0.0007
778 DISTURBANCE IN ATTENTION 35 0.0006
779 DEEP VEIN THROMBOSIS 42 0.0006
780 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
781 OFF LABEL USE 564 0.0006
782 LABORATORY TEST ABNORMAL 19 0.0006
783 WITHDRAWAL SYNDROME 27 0.0006
784 RHEUMATOID ARTHRITIS 73 0.0006
785 DISCOMFORT 39 0.0006
786 SECRETION DISCHARGE 8 0.0006
787 BONE DENSITY DECREASED 20 0.0006
788 DIALYSIS 9 0.0006
789 HAEMORRHAGE 66 0.0006
790 VIRAL INFECTION 21 0.0006
791 LIP SWELLING 21 0.0006
792 TOOTH DISORDER 14 0.0006
793 BLOOD BILIRUBIN INCREASED 17 0.0006
794 MULTIPLE SCLEROSIS 30 0.0006
795 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
796 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 126 0.0006
797 UNRESPONSIVE TO STIMULI 16 0.0006
798 FEELING HOT 38 0.0006
799 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
800 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
801 APATHY 9 0.0006
802 PROCEDURAL PAIN 17 0.0006
803 CHOLECYSTECTOMY 7 0.0006
804 PRODUCT USE ISSUE 115 0.0006
805 INJECTION SITE URTICARIA 15 0.0006
806 BONE DISORDER 11 0.0006
807 DRY SKIN 80 0.0006
808 PRODUCT PRESCRIBING ISSUE 13 0.0006
809 INJECTION SITE MASS 22 0.0006
810 CONJUNCTIVITIS 11 0.0006
811 PLATELET COUNT DECREASED 63 0.0006
812 DYSPHAGIA 56 0.0006
813 BACTERAEMIA 7 0.0006
814 DRUG DISPENSING ERROR 9 0.0006
815 SEIZURE 68 0.0006
816 THYROID DISORDER 9 0.0006
817 EMOTIONAL DISORDER 18 0.0006
818 INJECTION SITE WARMTH 12 0.0006
819 UNEVALUABLE EVENT 44 0.0006
820 RASH PAPULAR 13 0.0006
821 TOOTH LOSS 12 0.0006
822 STAPHYLOCOCCAL INFECTION 19 0.0006
823 ORAL DISCOMFORT 8 0.0006
824 SEPTIC SHOCK 25 0.0006
825 DRUG INEFFECTIVE 757 0.0006
826 HERPES ZOSTER 33 0.0006
827 WHITE BLOOD CELL COUNT DECREASED 62 0.0006
828 OCULAR HYPERAEMIA 27 0.0006
829 PNEUMOTHORAX 9 0.0006
830 BLINDNESS UNILATERAL 8 0.0006
831 LYMPHADENOPATHY 20 0.0006
832 BLINDNESS 23 0.0006
833 EMOTIONAL DISTRESS 68 0.0006
834 ERYTHEMA 115 0.0006
835 COLITIS ULCERATIVE 25 0.0006
836 CARDIOGENIC SHOCK 8 0.0006
837 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
838 BRAIN OEDEMA 7 0.0006
839 GASTRIC DISORDER 19 0.0006
840 HOSPITALISATION 85 0.0006
841 PNEUMONITIS 15 0.0006
842 NEOPLASM PROGRESSION 19 0.0005
843 PHOTOSENSITIVITY REACTION 9 0.0005
844 MYOCARDIAL INFARCTION 95 0.0005
845 SKIN BURNING SENSATION 39 0.0005
846 RESPIRATORY DISTRESS 15 0.0005
847 PSORIATIC ARTHROPATHY 22 0.0005
848 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
849 SKIN DISORDER 18 0.0005
850 BACTERIAL INFECTION 10 0.0005
851 BONE LOSS 8 0.0005
852 APPLICATION SITE PRURITUS 12 0.0005
853 GENERAL PHYSICAL HEALTH DETERIORATION 61 0.0005
854 ABASIA 13 0.0005
855 MULTIPLE SCLEROSIS RELAPSE 36 0.0005
856 INCREASED APPETITE 10 0.0005
857 DRUG EFFECT INCOMPLETE 19 0.0005
858 PULMONARY FIBROSIS 10 0.0005
859 DRUG EFFECT DECREASED 28 0.0005
860 RESTLESSNESS 19 0.0005
861 FEMUR FRACTURE 16 0.0005
862 INTERSTITIAL LUNG DISEASE 25 0.0005
863 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
864 PALLOR 14 0.0005
865 INTENTIONAL PRODUCT MISUSE 45 0.0005
866 HAEMATEMESIS 13 0.0005
867 ASCITES 15 0.0005
868 APPLICATION SITE RASH 7 0.0005
869 INJECTION SITE REACTION 35 0.0005
870 SENSORY DISTURBANCE 8 0.0005
871 DEAFNESS 13 0.0005
872 INCORRECT DOSE ADMINISTERED 113 0.0005
873 PRODUCT ADMINISTRATION ERROR 10 0.0005
874 THERAPEUTIC RESPONSE DECREASED 30 0.0005
875 RASH MACULO-PAPULAR 11 0.0005
876 DEVICE ISSUE 44 0.0005
877 BODY TEMPERATURE INCREASED 10 0.0005
878 METASTASES TO BONE 8 0.0005
879 PLASMA CELL MYELOMA 19 0.0005
880 TOXICITY TO VARIOUS AGENTS 82 0.0005
881 INJECTION SITE ERYTHEMA 60 0.0005
882 DRUG LEVEL INCREASED 8 0.0005
883 INJECTION SITE SWELLING 37 0.0005
884 INJECTION SITE PAIN 148 0.0005
885 NEEDLE ISSUE 14 0.0005
886 SKIN IRRITATION 22 0.0005
887 CARDIO-RESPIRATORY ARREST 20 0.0005
888 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 34 0.0005
889 MOOD ALTERED 13 0.0005
890 FRACTURE 9 0.0005
891 DEVICE DELIVERY SYSTEM ISSUE 13 0.0005
892 DERMATITIS ATOPIC 25 0.0005
893 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
894 TACHYCARDIA 42 0.0005
895 MOOD SWINGS 15 0.0005
896 IMPAIRED WORK ABILITY 10 0.0005
897 ADVERSE DRUG REACTION 42 0.0005
898 HIP FRACTURE 15 0.0005
899 THROMBOCYTOPENIA 52 0.0005
900 PRODUCT QUALITY ISSUE 63 0.0005
901 INJECTION SITE HAEMORRHAGE 37 0.0005
902 MULTI-ORGAN FAILURE 8 0.0005
903 DEVICE DEFECTIVE 8 0.0005
904 MENTAL DISORDER 20 0.0005
905 APPLICATION SITE ERYTHEMA 12 0.0005
906 DISEASE PROGRESSION 54 0.0005
907 ANAPHYLACTIC REACTION 25 0.0005
908 PSORIASIS 59 0.0005
909 PRESCRIBED UNDERDOSE 9 0.0005
910 LIVER DISORDER 20 0.0005
911 DELUSION 7 0.0005
912 TRANSAMINASES INCREASED 10 0.0004
913 ILL-DEFINED DISORDER 27 0.0004
914 ANGER 15 0.0004
915 DYSKINESIA 18 0.0004
916 COMA 21 0.0004
917 PNEUMONIA ASPIRATION 11 0.0004
918 RESPIRATORY DISORDER 13 0.0004
919 INJECTION SITE BRUISING 34 0.0004
920 UNDERDOSE 31 0.0004
921 THERAPY NON-RESPONDER 19 0.0004
922 ECZEMA 22 0.0004
923 DEVICE MALFUNCTION 29 0.0004
924 INJURY 29 0.0004
925 MENTAL IMPAIRMENT 10 0.0004
926 MALIGNANT NEOPLASM PROGRESSION 42 0.0004
927 APPLICATION SITE PAIN 9 0.0004
928 BREAST CANCER 38 0.0004
929 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
930 LACTIC ACIDOSIS 13 0.0004
931 ACCIDENTAL EXPOSURE TO PRODUCT 41 0.0004
932 ABDOMINAL PAIN LOWER 10 0.0004
933 DRUG DOSE OMISSION 65 0.0004
934 INJECTION SITE RASH 12 0.0004
935 PRODUCT PREPARATION ERROR 8 0.0004
936 IRRITABILITY 23 0.0004
937 MUCOSAL INFLAMMATION 10 0.0004
938 DERMATITIS 8 0.0004
939 LIVER FUNCTION TEST ABNORMAL 11 0.0004
940 BREAST CANCER FEMALE 10 0.0004
941 EXTRA DOSE ADMINISTERED 15 0.0004
942 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
943 CEREBRAL INFARCTION 9 0.0004
944 OSTEONECROSIS 12 0.0004
945 DRUG ADMINISTRATION ERROR 11 0.0004
946 AGITATION 26 0.0004
947 NEUTROPENIA 48 0.0004
948 PRODUCT AVAILABILITY ISSUE 8 0.0004
949 INCORRECT DOSE ADMINISTERED BY DEVICE 9 0.0003
950 DEATH 290 0.0003
951 HEPATIC FAILURE 10 0.0003
952 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
953 ENCEPHALOPATHY 8 0.0003
954 NERVOUS SYSTEM DISORDER 10 0.0003
955 ADVERSE EVENT 28 0.0003
956 ACNE 23 0.0003
957 PANIC ATTACK 11 0.0003
958 VAGINAL HAEMORRHAGE 13 0.0003
959 JAUNDICE 8 0.0003
960 INTENTIONAL OVERDOSE 19 0.0003
961 FREQUENT BOWEL MOVEMENTS 8 0.0003
962 DEVICE BREAKAGE 12 0.0003
963 SUICIDAL IDEATION 27 0.0003
964 LUNG NEOPLASM MALIGNANT 12 0.0003
965 DELIRIUM 10 0.0003
966 DRUG DOSE OMISSION BY DEVICE 22 0.0003
967 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13 0.0003
968 CRYING 10 0.0003
969 PRODUCT STORAGE ERROR 24 0.0003
970 RENAL CANCER 13 0.0003
971 MEDICATION ERROR 15 0.0003
972 OVERDOSE 58 0.0003
973 LEUKOPENIA 13 0.0003
974 DEVICE USE ERROR 9 0.0003
975 NEOPLASM MALIGNANT 17 0.0003
976 DEVICE LEAKAGE 11 0.0003
977 PANCYTOPENIA 14 0.0003
978 ACCIDENTAL OVERDOSE 9 0.0002
979 PROSTATE CANCER 19 0.0002
980 SUICIDE ATTEMPT 14 0.0002
981 CONVULSION 13 0.0002
982 NEUTROPHIL COUNT DECREASED 9 0.0002
983 DEVICE DIFFICULT TO USE 14 0.0002
984 FEBRILE NEUTROPENIA 14 0.0002
985 ABNORMAL BEHAVIOUR 8 0.0002
986 AGGRESSION 10 0.0002
987 TREATMENT FAILURE 16 0.0002
988 NO ADVERSE EVENT 33 0.0002
989 DEVICE DISLOCATION 7 0.0002
990 DRUG WITHDRAWAL SYNDROME 12 0.0001
991 DRUG DEPENDENCE 9 0.0001